Askel Healthcare is a Finnish medical technology company set to transform surgical knee cartilage treatment and recovery. Our mission is to keep people in motion through our universal COPLA® implant, which is a ground-breaking innovation for the repair of knee cartilage defects.
Steps of your life
We keep people in motion
Askel is your partner for life
Our mission is to keep people in motion. We will accomplish this by transforming the surgical treatment of knee cartilage defects with our universal COPLA® implant.
Askel is your partner for life. Our purpose is to ensure that you can maintain an active lifestyle. We embrace scientific evidence and value the impact it can bring to human health. We are confident in what we do, and we will treat you with respect and a positive attitude. Our values, which are thrive, authenticity, humor, and empathy, guide our everyday work and purpose.
The joint surface is composed of cartilage and underlying bone. The cartilage over the bone functions as a cushioning and lubricating surface and its health is essential for our ability to move pain-free.
Unlike bone, cartilage has very limited self-healing capacity due to the absence of blood vessels and a low number of cells. If a damaged joint surface is left untreated, the problem can escalate into further joint degeneration and osteoarthritis, which is a chronic degenerative joint disease affecting the whole joint as an organ.
Therefore, it is essential to treat cartilage lesions in a timely and efficient manner.
COPLA® is an investigational device and is not yet approved for commercial use in any country. The described design properties and intended purpose are subject to further validation.
The COPLA® cartilage implant is not yet available for commercial use but has entered the first in-human clinical trial phase. COPLA® is intended for the treatment of symptomatic, full-thickness cartilage and bone-cartilage lesions in the knee joints of adult patients. It is a biodegradable polymer scaffold that allows for immediate full weight-bearing after surgery.
COPLA® cartilage implant
COPLA® is an investigational device and is not yet approved for commercial use in any country.
COPLA® is indicated for the treatment of symptomatic, full-thickness cartilage and bone-cartilage lesions in the knee joints of adult patients. It is a biodegradable polymer scaffold that allows for immediate full weight-bearing after surgery.